Despite activating hotspots in NFE2L2 and inactivating mutations in its negative regulators, KEAP1, CUL3, and SIRT1 have been reported, they do not justify themselves the overexpression of NRF2 transcriptional signature in the different tumor types. Here, KEAP1 is linked to neoplasm.